BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6033664)

  • 1. Glycogen phosphorylase: a specific secondary target system for adrenergic stimulation in the heart.
    Oye I
    Acta Physiol Scand; 1967 Apr; 69(4):270-5. PubMed ID: 6033664
    [No Abstract]   [Full Text] [Related]  

  • 2. Influence of INPEA, pindolol and propranolol on the chronotropic and metabolic responses to -adrenergic stimulation in intact rats.
    Robak J; Gryglewski R
    Biochem Pharmacol; 1971 Oct; 20(10):2749-58. PubMed ID: 4398866
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of adrenergic agents on carbohydrate metabolism of rat liver: activities of adenyl cyclase and glycogen phosphorylase.
    Newton NE; Hornbrook KR
    J Pharmacol Exp Ther; 1972 Jun; 181(3):479-88. PubMed ID: 5033014
    [No Abstract]   [Full Text] [Related]  

  • 4. Interactions of acetylcholine and epinephrine on contractility, glycogen and phosphorylase activity of isolated mammalian hearts.
    Blukoo-Allotey JA; Vincent NH; Ellis S
    J Pharmacol Exp Ther; 1969 Nov; 170(1):27-36. PubMed ID: 5351004
    [No Abstract]   [Full Text] [Related]  

  • 5. Adrenergic regulation of glycogen breakdown in the heart and skeletal muscle. The role of alpha-adrenergic receptor.
    Dynarowicz I
    Acta Physiol Pol; 1974; 25(2):151-8. PubMed ID: 4151526
    [No Abstract]   [Full Text] [Related]  

  • 6. Adrenergic mechanisms in cardiac glycogen metabolism.
    Mayer SE; Williams BJ; Smith JM
    Ann N Y Acad Sci; 1967 Feb; 139(3):686-702. PubMed ID: 4382728
    [No Abstract]   [Full Text] [Related]  

  • 7. Opposite effects of amiodarone and -blocking agents on cardiac function under adrenergic stimulation.
    Charlier R; Delaunois G; Bauthier J
    Arzneimittelforschung; 1972 Mar; 22(3):545-52. PubMed ID: 4402603
    [No Abstract]   [Full Text] [Related]  

  • 8. [Action of adrenaline and noradrenaline on the resistance of the heart to hypoxia].
    Markova EA; Koptiukh VV
    Fiziol Zh; 1976 MAR-APR; 22(3):343-8. PubMed ID: 1278473
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of oxprenolol on coronary circulation and cardiac metabolism.
    Drimal J; Aviado DM
    J Pharmacol Exp Ther; 1971 Feb; 176(2):312-9. PubMed ID: 4398185
    [No Abstract]   [Full Text] [Related]  

  • 10. [Possiblities of dissociation of the effects of noradrenaline on inotropism and on phosphorylase activity of the heart].
    Lacroix E; Weyne J; Leusen I
    C R Seances Soc Biol Fil; 1967; 161(11):2338-41. PubMed ID: 4232268
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of potassium and calcium ions in the effect of epinephrine on cardiac cyclic adenosine 3',5'-monophosphate, phosphorylase kinase, and phosphorylase.
    Namm DH; Mayer SE; Maltbie M
    Mol Pharmacol; 1968 Sep; 4(5):522-30. PubMed ID: 4301278
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of adrenal cortical hormones and thyroxine on phosphorylase activity in muscle.
    Hess ME; Aronson CE; Hottenstein DW; Karp JS
    Endocrinology; 1969 May; 84(5):1107-12. PubMed ID: 4305000
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of adrenergic agonists and antagonists on adenylate cyclase activity of dog heart and liver.
    Mayer SE
    J Pharmacol Exp Ther; 1972 Apr; 181(1):116-25. PubMed ID: 4335168
    [No Abstract]   [Full Text] [Related]  

  • 14. [Relationship between thyroid hormones and catecholamines. Studies cardiac phosphorylase activity and the heart rate as their index].
    Oikawa R
    Nihon Naibunpi Gakkai Zasshi; 1969 Sep; 45(6):599-612. PubMed ID: 5388344
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of variations of pH upon the activation of phosphorylase by epinephrine in perfused contracting heart, liver slices and skeletal muscle.
    Reynolds RC; Haugaard N
    J Pharmacol Exp Ther; 1967 Jun; 156(3):417-25. PubMed ID: 4381799
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of adrenergic alpha- and beta-receptor blocking drugs on the myocardial lesions induced by sympathomimetic amines.
    Méhes G; Papp G; Rajkovits K
    Acta Physiol Acad Sci Hung; 1967; 32(1):175-84. PubMed ID: 6080429
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of thyroxine on rat heart adenosine 3',5'-monophosphate, phosphorylase b kinase and phosphorylase a activity.
    Frazer A; Hess ME; Shanfeld J
    J Pharmacol Exp Ther; 1969 Nov; 170(1):10-6. PubMed ID: 4390812
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical pharmacology of beta-sympathicolysis. Comparative trial of LB 46 and propranolol].
    Lang E; Haas W; Heck J
    Med Klin; 1970 Dec; 65(50):2206-11. PubMed ID: 4399179
    [No Abstract]   [Full Text] [Related]  

  • 19. Cardiac dynamics of dl-propranolol (Inderal), d-propranolol, and practolol (AY 21011, ICI 50172): a preliminary study.
    Victor M; Alter J; Terry WH; Kilmore MA
    J Am Osteopath Assoc; 1970 Jun; 69(10):1045-6. PubMed ID: 5201430
    [No Abstract]   [Full Text] [Related]  

  • 20. [Phosphorylase in the frog heart: variation of activity induced with adrenaline and work].
    Piery Y; Grably S
    C R Seances Soc Biol Fil; 1969; 163(4):870-2. PubMed ID: 4259086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.